Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings

Table 2

Author	Drug	Number of cases	Benefit
Thijs et al., 2010 [12]	Temsirolimus	1	PFS 40 weeks
Lopez-Gonzales, 2011 [13]	Cisplatin-Campto trabectedin	1	PDPFS 8 months
Chao, 2010	Imatinib mesylate	2	PFS 0.2 and 1.1 months
Mrabti et al., 2011 [14]	Anthracyclin	1	—
Outc’s observatory ASCO 2010 #10097	Sunitinib	2	PFS 2 and 6 months
Outc’s observatory ASCO 2010 #10097	Sorafenib	2	PFS 3 months: stop at 3 months for toxicity